Botanical species · safety record

Bontia daphnoides

The EFSA Compendium of Botanicals holds 4 constituent measurements for Bontia daphnoides. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Bontia daphnoides L.

4Constituent measurements
0Safety records
2Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Epingaione3
  • Ngaione1

Plant parts

  • Leaves3
  • Stem1
  • stalk1

Preparations

  • Solvent extraction4

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
EpingaioneLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
NgaioneLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
EpingaioneStem / stalkSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
EpingaioneLeavesSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. CHINNOCK, RJ., GHISALBERTI, EL., JEFFERIES, PR. (-)-EPINGAIONE FROM BONTIA-DAPHNOIDES. PHYTOCHEMISTRY, 1987, vol. 26, no. 4, p. 1202-1203. DOI
  2. Williams, L. A. D., Conrad, J., Vogler, B., Roesner, H., Porter, R. B. R., Setzer, W., Barton, E. N., Levy, H. G., Mika, S., Klaiber, I., Nkurunziza, J. P., Kraus, W. In vitro anti-proliferation/cytotoxic activity of epingaione and its derivatives on the human SH-SY5Y neuroblastoma and TE-671 sarcoma cells. WEST INDIAN MEDICAL JOURNAL, 2007, vol. 56, no. 1, p. 5-10.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue